https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-lshc-2016-life-sciences-outlook.pdf https://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069962.htm https://www.zs.com/about/news-and-events/as-doctors-keep-closing-doors-on-pharma-reps.aspx SOLUTIONS PROBLEMS MicroStrategy mobile apps help commercial sales reps tailor their interactions with physicians so they can make the most effective use of limited meeting times. MicroStrategy solutions help pharma executives optimize their supply chain, marketing, and sales operations in order to maximize the returns on new product offerings. MicroStrategy security solutions help life sciences companies protect intellectual property and sensitive clinical data using sophisticated physical and logical access controls. MicroStrategy helps drug companies monitor and analyze their complex global distribution networks to surface hidden performance issues and uncover potential counterfeiting situations. MicroStrategy helps marketing executives gauge the effectiveness of advertising campaigns by analyzing their influence on drug purchases and prescription renewals. TASKS EXECUTIVE DASHBOARD MARKETING PERFORMANCE DIGITAL EMPLOYEE BADGE DISTRIBUTION ANALYSIS FIELD SALES ENABLEMENT Leading biotech and pharmaceutical companies rely on MicroStrategy solutions to bring new products to market faster and to maximize the return on their development investments. Learn more at microstrategy.com/solutions/biotechandpharma Operating in intensely competitive global markets, life sciences companies need powerful analytical solutions to accelerate drug development and optimize marketing and sales activities. HOW BIOTECH & PHARMA COMPANIES USE ANALYTICS TO BRING INSIGHT AND EFFICIENCY TO EVERY ASPECT OF THEIR VALUE CHAINS https://www.statnews.com/2016/03/09/drug-industry-advertising/ IN THE US, PHARMA COMPANIES RECEIVE A 5-YEAR PERIOD OF MARKET EXCLUSIVITY FOR NEWLY APPROVED DRUGS Drug makers spent $5.2 BILLION on TV and print advertising in 2015 In 2011, the UK’s life sciences and health care industry suffered $2.9 billion in losses due to IP theft. http://trade.gov/topmarkets/pdf/Pharmaceuticals_Executive_Summary.pdf The size of the global counterfeit drug market is estimated to be as high as $200 billion, and can make up of all drugs sold in some countries. 44% of physicians are considered “accessible” to sales reps. Based on a 2016 study, just 1/2